For years, women were warned that hormone replacement therapy (HRT) carried major risks, including breast cancer, heart disease, and dementia.
These warnings shaped medical decisions for more than two decades and left many women struggling through menopause without options.
That picture has changed.
In 2025, the FDA began removing misleading black box warnings from many menopausal hormone therapy products.
This update reflects newer, clearer evidence showing that the old warnings overstated the risks for most women who start therapy around the time of menopause.
Quick Answer: Why Did the FDA Remove the Warning?
The FDA removed several black box warnings after updated scientific reviews confirmed that the original labels were based on outdated interpretations from older studies.
For most women who begin hormone therapy before age 60 or within 10 years of menopause, the risks are far lower and the benefits are far greater than the old warnings suggested.
Why the Black Box Warning Existed in the First Place
The original warnings stemmed from the Women’s Health Initiative (WHI) published in 2002.
At the time, results appeared to show increased risks for breast cancer, cardiovascular disease, and cognitive decline.
However, those early conclusions did not tell the whole story:
- The average participant was 63, well beyond the typical age for starting HRT.
- Many were already at higher risk of chronic disease due to age.
- Researchers later determined that timing was a critical factor that the early interpretation overlooked.
- The findings were applied to all women, even those newly entering menopause.
Those broad warnings shaped clinical practice for decades, even as newer studies painted a different picture.
Why Did the FDA Remove the Black Box Warning?
The FDA’s updated position follows an extensive review of more recent evidence.
Modern research shows that risk is closely tied to when a woman starts therapy, not simply whether she uses hormones.
The science behind the change includes:
- Women who start HRT before age 60 or within 10 years of menopause generally have a more favorable risk profile.
- Earlier fears about cardiovascular disease were linked to women who began therapy much later in life.
- The association between HRT and dementia was found to apply mainly to older women who started therapy long after menopause.
- Benefits such as relief from hot flashes, bone protection, better sleep, mood support, and improved quality of life are significant for many women.
This combination of findings led to the decision that the previous warnings were misleading for most appropriate candidates.
What Changed and What Stayed the Same
Here is a simple breakdown of the updates:
HRT Warnings Removed
The FDA removed black box warnings related to:
- Breast cancer
- Cardiovascular disease
- Probable dementia
These warnings no longer reflect the current evidence for women who begin therapy at the appropriate time.
HRT Warning That Remains
One important warning stays:
- Endometrial cancer risk for estrogen-only therapy in women who still have a uterus
This has always been a known risk and is prevented by adding progesterone.
Comparison: Old Understanding vs Updated Evidence
| Topic | Old Understanding | Updated Evidence Today |
| Heart Disease Risk | HRT increases heart disease risk for all women | Studies show risk is lower when started near menopause; timing plays a major role |
| Breast Cancer Risk | Increased risk for all hormone therapy users | Not increased for most women who start early; varies by formulation and individual risk |
| Dementia Risk | HRT increases dementia risk | Only applies to older women starting therapy long after menopause |
| Endometrial Cancer Risk | All hormone therapy increases risk | Only estrogen-alone therapy in women with a uterus raises risk |
| Overall Recommendation | Avoid HRT when possible | Safe and beneficial for many women when used appropriately and started at the right time |
What the New Labeling Means for Women
This update does not mean every woman should take hormones.
It means women can now make decisions based on accurate information, not fear driven by outdated labels.
Women who may benefit include:
- Those entering menopause with disruptive symptoms
- Women under 60
- Women within 10 years of their last menstrual period
- Women seeking bone protection or improvement in sleep, mood, or quality of life
- Women who were previously told they “couldn’t” use hormones based on the old warning
If you fall into one of these groups, the new guidance opens the door to a clearer conversation about whether HRT is right for you.
Is Hormone Replacement Therapy Safer Now?
For many women, yes, when started at the right time and used appropriately.
Key factors influencing safety include:
- Age at the start of therapy
- Time since menopause
- Type of hormone (estrogen-only vs estrogen + progesterone)
- Route of administration (patches, tablets, creams, injections)
- Personal and family health history
This is why the decision should always be individualized.
Systemic vs Local Hormone Therapy: What’s the Difference?
Let’s take a look at the difference between systemic and local hormone therapy:
Systemic Therapy
- Treats whole-body menopause symptoms
- Helps with hot flashes, night sweats, sleep problems, mood changes
- Available as patches, oral tablets, creams, gels, or injections
Local (Vaginal) Therapy
- Targets symptoms like dryness, pain during intercourse, and urinary irritation
- Carries minimal systemic absorption
- Has always been considered one of the safest options for most women
Understanding the difference can help you choose the therapy that matches your symptoms and goals.
What Risks Should Women Still Keep in Mind?
Even with updated labeling, some considerations remain:
- Estrogen-only therapy increases the risk of endometrial cancer for women with a uterus unless paired with progesterone.
- Starting HRT much later in life may not provide the same benefits and may carry different risks.
- Women with certain medical histories, such as hormonally sensitive cancers, need individualized guidance.
These factors should be discussed one-on-one with a clinician who understands both the benefits and limitations of hormone therapy.
A Quick Guide for Your Next Appointment
Bring these questions with you:
- Am I a good candidate for hormone therapy?
- Should I choose systemic therapy or local/vaginal estrogen?
- What real risks apply to someone my age and health profile?
- What benefits can I expect in the first few months?
- How will you monitor my progress and safety?
Clear, confident conversations start with good information and the FDA’s updated labeling finally supports that.
How Protocol Health Approaches These Conversations
At Protocol Health, many women tell us they avoided hormone therapy for years because they were frightened by the old warnings.
The updated labeling allows for more informed, balanced discussions.
Our clinical team focuses on understanding your symptoms, your health history, and your goals so you can make the choice that feels right for you.
Conclusion
The FDA’s decision to remove misleading warnings from hormone replacement therapy marks a turning point in women’s health.
For decades, many women made decisions based on outdated interpretations of older studies, often opting to struggle through menopause without the support that modern research shows can be safe and effective for many.
With clearer labeling, women and clinicians can now move forward with better information, more confidence, and a more accurate understanding of the true risks and benefits of hormone therapy.
If you’ve been unsure about HRT in the past, now is the time to revisit the conversation with up-to-date guidance.
Relief, clarity, and a better quality of life are possible when decisions are grounded in current evidence and tailored to your unique health needs.
FAQs: FDA Removes Misleading Warnings on Hormone Replacement Therapy
What are the pros and cons of HRT?
The benefits of hormone replacement therapy often include relief from hot flashes, better sleep, improved mood, increased energy, and protection against bone loss. The drawbacks depend on age, timing, and health history. Some women may experience breast tenderness, spotting, or mild bloating early on, and certain health conditions may require caution. Overall, the balance of pros and cons is highly individual.
Is HRT safe for me now?
Many women under 60 or within 10 years of menopause are considered good candidates for hormone therapy, depending on their personal and family medical history. The FDA’s updated labeling reflects that the risks once associated with HRT were overstated for most women starting therapy at the appropriate time. A clinician familiar with hormone therapy can help determine your individual safety profile.
What are the weird symptoms of low estrogen?
Low estrogen can cause a surprising range of symptoms, including dry eyes, joint stiffness, dental sensitivity, itchy skin, electric shock sensations, and a feeling of internal heat rather than classic hot flashes. Some women also report heart palpitations, brain fog, or increased anxiety during the transition through menopause.
How long does estrogen stay in your system?
This depends on the type and route of therapy. Oral estrogen typically clears within a day or two. Transdermal patches and gels may have effects that last slightly longer as the hormone is absorbed gradually. Vaginal estrogen products vary based on formulation, with some offering extended local effects. In general, most systemic estrogen leaves the system within a few days.
What are the side effects of stopping HRT suddenly?
Stopping hormone therapy abruptly may lead to the return of symptoms such as night sweats, hot flashes, mood swings, and sleep disturbances. Some women also experience joint pain, headaches, or a sudden drop in energy. In many cases, tapering slowly under medical guidance can make the transition smoother and more comfortable.
